Icosapent ethyl for reduction of persistent cardiovascular risk: a critical review of major medical society guidelines and statements-Reference-Cited by-同舟云学术

Icosapent ethyl for reduction of persistent cardiovascular risk: a critical review of major medical society guidelines and statements

Published:2022-07-28 Issue:8 Volume:20 Page:609-625
ISSN:1477-9072
Container-title:Expert Review of Cardiovascular Therapy
language:en
Short-container-title:Expert Review of Cardiovascular Therapy

Author:

Miller Michael¹²,Tokgozoglu Lale³^ORCID,Parhofer Klaus G.⁴,Handelsman Yehuda⁵,Leiter Lawrence A.⁶,Landmesser Ulf⁷,Brinton Eliot A.⁸,Catapano Alberico L.⁹

Affiliation:

1. Department of Medicine, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA

2. Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA

3. Department of Medicine, Hacettepe University, Ankara, Turkey

4. Department of Medicine, Medizinische Klinik IV – Grosshadern, Klinikum der Universität München, Munich, Germany

5. Department of Medicine, Metabolic Institute of America, Tarzana, CA, USA

6. Department of Medicine, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada

7. Department of Medicine, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Berlin, Germany

8. Department of Medicine, Utah Lipid Center, Salt Lake City, UT, USA

9. Department of Medicine, University of Milan and Multimedica IRCCS, Milan, Italy

Funder

Amarin Pharma, Inc

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14779072.2022.2103541

Reference156 articles.

1. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol

2. Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

3. Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eicosapentanoic Acid Supplementation for Atherosclerotic Cardiovascular Disease Prevention;Circulation;2024-08-06

2. Long chain n-3 polyunsaturated fatty acid intake across the life span for cardiovascular disease prevention in women;Proceedings of the Nutrition Society;2024-03-06

3. Pleiotropic beneficial cardiometabolic actions of a high‐purity eicosapentaenoic acid product in high cardiovascular risk individuals;Lipids;2024-02-21

4. Integrating Artificial Intelligence for Drug Discovery in the Context of Revolutionizing Drug Delivery;Life;2024-02-07

5. Intermediate and long-term residual cardiovascular risk in patients with established cardiovascular disease treated with statins;Frontiers in Cardiovascular Medicine;2024-01-15